Recruiting NA Pregnancy in Diabetic

New treatment option for Pregnancy in Diabetic

Official title Characterization of Placental Diffusion

ClinicalTrials.gov ID: NCT06992245

What this study is testing

What it's testing
DW-MRI Allows a quantitative comparison of diffusion as an expression of tissue hypoxia. The investigators aim is to compare changes in placental diffusion in pregnant women with uncontrolled diabetes compared to healthy pregnant women using DW-MRI.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 50, women only. Healthy volunteers may be eligible.

You may be able to join if

  • Women with PGAM (Pre-gestational diabetes) diagnosed before 20 weeks of pregnancy
  • Women with GDMA (Gestational diabetes) diagnosed by OGTT after 20 weeks of pregnancy

You likely can't join if

  • pregnant women with placental hypoxia disease related in the past
  • pregnant women with placental hypoxia disease related in the present
  • non-singleton pregnancy
  • women in active labor or rupture of membrane
  • smoking women
  • suspicion of placenta accreta

The study team makes the final eligibility decision.

Where it's taking place

  • Hadera, Israel

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Hadera, Israel. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.